A STUDY ON THE PREVALENCE OF PRIMARY DRUG RESISTANCE AMONG PULMONARY TUBERCULOUS PATIENTS OBSERVED DURING THE PERIOD FROM 1955 TO 1963:Analysis on the Factors Affecting the Prevalence Rate
スポンサーリンク
概要
- 論文の詳細を見る
A study was made on the prevalence of primary drug resistance for major 3 anti-tuberculous, drugs among 838 cases of pulmonary tuberculosis without any previous history of chemotherapy observed during the period from 1955 to 1963. Cases were collected from 2 sanatoria and 3 dispensaries belonging to the Japan Anti-tuberculosis Association in Tokyo.<BR>Drug sensitivity was tested indirectly among 792 cases, and directly among 46 cases. The latter was used among smear positive cases. Most of the drug sensitivity test was performed. indirectly by inoculating the suspension prepared from the isolation culture of sputum, laryngeal swab or gastric lavage. Amount of inoculated bacilli was 10<SUP>-1</SUP>mg up to 1957, and 10<SUP>-1</SUP>mg since 1958.<BR>Concentration of drugs in media before coagulation was as follows: SM 20 and 200 mcg/m<I>l</I>, PAS 1 and 10 mcg/m<I>l</I>, and INH 0.1, 1 and 5 mcg/m<I>l</I>. In the case of SM, approximately half was absorbed by the medium, and the results of sensitivity test on SM was demonstrated finally as 10 and 100mcg/m<I>l</I> respectively. 3% Ogawa's egg medium was used for direct method, and. 1% Ogawa's egg medium was used for indirect method.<BR>Criteria of resistance was shown in Table 1, and the results were summarized as follows:<BR>1. The number of primary drug resistant cases was 109, and the rate to the total cases was 13.0%.<BR>2. The rate during the period from 1955 to 1957 was 24.0%, and was significantly higher than the rate during the period from 1958 to 1963 (9.9%). Since 1958, no marked difference was observed among the rates in the recent 6 years.<BR>3. The rate of resistance to each drug was shown in Table 2. The rates for SM and PAS was nearly the same, and the rate for INH was approximately one third of the rates for SM and PAS. If the level of drug resistance for INH was lowered to include the cases completely resistant to 0.1mcg/m<I>l</I> or incompletely resistant to 0.1 and 1mcg/m<I>l</I>, the rates for INH during the period from to 1958 to 1963 increased to 9.1, 5.6, 4.1, 6.5, 4.5 and 4.3% respectively, which were nearly the same to the rates of resistance for SM and PAS.<BR>4. Among many factors, sex, previous history of BCG vaccination, kinds of specimens tested, and the amount of bacilli growth on isolation culture gave no influence on the rate of primary drug resistance. The rate was slightly higher among younger cases, recently converted cases, avitary cases and more extensive cases than among older cases, previously converted cases, non-cavitary cases and slight ceses, raspectively.<BR>5. The most marked difference in the rate of resistant cases was observed by the amount of bacilli growth on the control media. As shown in Table 3, the rate increased with the increase of bacilli growth on the control media, and the rate of # group was markedly higher than the other 3 groups. Comparing the rate of # group by the period, the rate during the period from 1955 to 1957 was significantly higher than that from 1958 to 1963. This difference was explained by the difference in the amount of inoculum, and 10<SUP>-1</SUP>mg inoculation is considered to be inadequate to determine the primary drug resistance.<BR>6. Cases completely resistant to 5mcg/m<I>l</I> INH was observed in 2 cases.
- 一般社団法人 日本結核病学会の論文
著者
-
瀬倉 敬
結核予防会研究委員会
-
日置 治男
結核予防会研究委員会
-
橋本 芳郎
結核予防会研究委員会
-
日置 治男
結核予防会保生園
-
山口 智道
結核予防会研究委員会
-
大里 敏雄
結核予防会研究委員会
-
木下 次子
結核予防会渋谷診療所
-
木野 智慧光
結核予防会研究委員会
-
橋本 芳郎
結核予防会保生園
-
草光 宜平
結核予防会研究委員会
関連論文
- 313 肺癌と鑑別を要した肺野孤立性結核例の検討
- 28 重症喘息発作時におけるハロセンとエンフルレンの使用経験
- 159 喘息死への気管支攣縮と粘液栓の関与について : 病理像からの検討
- 12. 気管支リンパ節瘻を呈した肺門リンパ節結核の 1 例(第 61 回日本気管支学会関東支部会)
- 潜在結核感染症治療中に発生した肝機能障害
- 肺結核患者の療養指導に関する研究
- 外来患者における非定型抗酸菌の検出と非定型抗酸菌症の治験
- 実験結核症に対する4,4-diisoamyloxy-thiocarbanilide(lsoxyl)の抗結核作用について
- 肺結核化学療法の短期化の試み
- 薬剤耐性菌感染に関する研究
- STC [2, 3-dipheny1-5-thienyl-(2)-tetrazolium chloride] の応用による結核菌発育の早期判定に関する研究 : 第4報STC含有培地の分離培養への応用に関する研究
- STC [2, 3-diphenyl-5-thienyl-(2)-tetrazolium chloride] の応用による結核菌発育の早期判定に関する研究 : 第3報 STC含有培地に関する研究
- Tuberactinomycin-Nの臨床成績
- Rifampicin耐性結核菌の毒力に関する実験的研究 (予報)
- Tuberactinomycinの臨床成績
- STC[2,3-dipheny1-5-thienyl-(2)-tetrazoliumchloride]の応用による結核菌発育の早期判定に関する研究 : 第1報STCの応用による結核菌発育の早期判定に関する基礎的研究
- 薬剤耐性菌感染に関する研究
- Kanamycin耐性菌に対するViomycinおよびCapreomycinの抗菌力KMとVM, CPMの交叉耐性に関する研究
- 肺結核症に對する「303」製剤療法の研究 : (第二報)病理解剖学的所見
- RFP使用中に陰影増大をみた肺結核切除例の組織学的観察 : その発症要因の考察
- 抗結核薬の副作用防止に関する研究 : 特にPantethineの効果について
- リンパ節結核に対するRifampicinの治療効果に関する研究
- 結核菌のThiacetazone耐性に関する研究 : 第3編ThiacetazoneとEthionamideの交叉耐性に関する研究
- 薬剤耐性菌感染に関する研究 : 第4編低耐性菌感染に関する実験的研究
- 薬剤耐性菌感染に関する研究
- Clinical study of TCR γ δ cell in peripheral blood of Sarcoidosis
- 医療と健康管理における意志決定の根拠 (第57回日本結核病学会総会)
- 化学療法と外科療法の境界 外科の立場より
- タイトル無し
- A STUDY ON THE PREVALENCE OF PRIMARY DRUG RESISTANCE AMONG PULMONARY TUBERCULOUS PATIENTS OBSERVED DURING THE PERIOD FROM 1955 TO 1963:Analysis on the Factors Affecting the Prevalence Rate
- タイトル無し
- Clinical Study on Ambulatory Chemoterapy for Drug Resistant cases of Pulmonary Tuber culosis-Methods of Treatment for Such cases.
- タイトル無し
- タイトル無し
- STUDIES ON THE TRANSITION OF SENSITIVITY FOR SM, INH AND PAS OF TUBERCLE BACILLI ISOLATED FROM THE PATIENTS TREATED BY TRIPLE COMBINATION CHEMOTHERAPY INCLUDING SM AND INH WITH SPECIAL REFERENCE TO THEIR CLINICAL COURSE
- タイトル無し
- タイトル無し
- タイトル無し